Osicent 80 mg side effects
Osicent 80 mg is a pharmaceutical formulation containing osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). It is primarily used to treat certain types of non-small cell lung cancer (NSCLC) that exhibit specific genetic mutations. Manufactured for advanced therapeutic interventions, Osicent is pivotal in precision oncology, targeting cancers with EGFR mutations, […]
